Skip to Content

Hainan Shuangcheng Pharmaceuticals Co Ltd Class A 002693

Morningstar Rating
CNY 5.65 −0.46 (7.53%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

002693 is trading within a range we consider fairly valued.
Price
CNY 5.97
Fair Value
CNY 7.15
Uncertainty
Extreme
1-Star Price
CNY 48.15
5-Star Price
CNY 9.18
Economic Moat
Jsxk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 002693 is a good fit for your portfolio.

Trading Information

Previous Close Price
CNY 6.11
Day Range
CNY 5.635.94
52-Week Range
CNY 3.679.72
Bid/Ask
CNY 5.64 / CNY 5.65
Market Cap
CNY 2.35 Bil
Volume/Avg
28.2 Mil / 16.6 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
13.14
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
474

Comparables

Valuation

Metric
002693
300016
000915
Price/Earnings (Normalized)
14.59
Price/Book Value
5.501.612.68
Price/Sales
13.142.913.38
Price/Cash Flow
328.7845.637.90
Price/Earnings
002693
300016
000915

Financial Strength

Metric
002693
300016
000915
Quick Ratio
0.442.84
Current Ratio
0.743.76
Interest Coverage
−0.28−0.39
Quick Ratio
002693
300016
000915

Profitability

Metric
002693
300016
000915
Return on Assets (Normalized)
−4.75%−2.34%11.61%
Return on Equity (Normalized)
−8.05%−3.88%20.00%
Return on Invested Capital (Normalized)
−4.32%−1.18%13.38%
Return on Assets
002693
300016
000915
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ANkzrkbqjBfdbc$76.9 Bil
MKKGY
Merck KGaA ADRNlmkbsdvZckbnpl$72.0 Bil
HLN
Haleon PLC ADRSwpdxmhGfvk$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRLhbtszjftZgvpm$17.9 Bil
VTRS
Viatris IncCjnkywhVcwsz$13.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRJgwccwsFkfml$11.7 Bil
CTLT
Catalent IncGykhsvfjrGgqzqn$10.1 Bil
PRGO
Perrigo Co PLCDkyztznzYqlv$4.2 Bil
CURLF
Curaleaf Holdings IncFnhggdsvLksp$4.0 Bil
PBH
Prestige Consumer Healthcare IncJjtwrprPjrqffc$3.5 Bil

Sponsor Center